Now THAT kind of talk is worth a call to the Howarth! Even if they had to go to a BDC and pay 15%, the implicit after-tax rate might be about 10% (not that they have any profits to offset the interest against, but maybe they can carry it forward and use it next year).
That means that if they bought back stock at 2, they only have to get the remaining stock to 2.2 within a year, to break even on the deal.
I guess the trouble is that on such a (usually) thinly-traded stock, the news that that's what they want to do would itself bid up the PPS. Can't they get MS and GS to slag the stock some more, all while agreeing to get hold of 50m units of at a fixed price? Just kidding, but, great post, shakey.
Almost certainly Adobe Flash Player. That thing is MURDER. I open Task Manager and kill it, several times a day. Adobe runs all the video ads that you don't want to see anyway.
Regarding "Gee. If they announced...": now you add ignorance to the mental difficulties! On Sep-15, they annonunced there would be a webcast "...after the close of....current quarter, to provide a business update". So they were ALWAYS going to be apprised of developments BEFORE the end of the quarter (eg. today), AT the webcast time.
If they were worried something might emerge between Oct-1 and Oct-3, but AFTER the webcast, then why not just pre-announce Friday AH??
That means we have to look ELSEWHERE for the explanation than the sort of childish thinking you and the original poster provide.
Completely agree. Since there must actually be a reason (other than Tom's wife hasn't decided which day she wants them to play golf this week), it has to come from OUTSIDE GT, or at least there is some interaction between the desirable meeting timing, and events not yet known on Sep-15.
Presumably it's the NDA again, and Apple TOLD them to delay guidance or business news UNTIL some parameters about the launch, or about production, have been ascertained. GT may even be waiting on the 4th payment right now, and want to include it. Any other ideas?
john: I don't think I'm going to get through to you, because you seem to have some pretty serious intellectual problems, but here goes:
how would announcing the date stop them adding the sapphire sales (that they learned about after the date_announcement, and before the date_itself)?
I guess it's not really all that important, but it is a very odd way to go about things - and not very business-like. And it's certainly shown up the intellectual attainement of some of the folks that invest in this thing.
Lovely, but doesn't stop them announcing when the pharcking thing is. Why not have just said "Friday Oct-3, 4.00pm ET" back on Sep-15? Why the drama about when? I am altogether too Long, but I cannot understand the failure to say when. If it really had to do with the exact Q3 figures, they probably couldn't do it this week at all. That's basically why the Q3 cc won't be till Nov.
coward: like circusboring, I don't think shorting is a crime against humanity. Makes no difference that I'm disgustingly Long.
But I think your post would have benefited from an explanation of WHY you think it will hit $8 after the call - lowered guidance, disappointing sales in other areas, etc.. Just recounting one's position/sentiment is of limited interest, I think. There are, after all, apparently so many reasons for optimism among Longs, especially relative to the current PPS. What do you have? I'm picturing your GF on a motorscooter.
mike, if you thought I was being snarky because I missed an opportunity to short at 20, or even 10, well - I wuzn't! I meant nothing more than you saved me from the 6-to-20 runup. Besides, your don't-touch-it-with-a-bargepole perspective is surely excellent advice to the average retailer.
Thanks for turning us on to "ACTH prophylactic treatment of renal disorders US 8796416 B1". Does that really mean poor Martin cannot develop RE-034 anymore, ie. the patent would be deemed good for any form of ACTH for any kind of renal failure?
Don't bother to reply to this way down here, it's worth a fresh thread, if anything. Probably discussed on RTRX board, I should head there, but it's all Memory Lane for me, as RTRX is off-limits!
Just want to confirn for newbies that mikey DID say this a year ago! It was in response to naive blather from me that I wanted to short it (it was aound 6 at the time). It subsequently rose above 20.
Many times since has my finger hovered over the Sell-Short button, but I ALWAYS remembered mkf's post on the ownership structure of the shares, and went and shorted WDAY and CRM instead. One of the many ways he helped attain my, er, financial goals (just saying).
td: given your admirably pithy and incontrovertible A-B summary, it seems amazing that the legal expenses continue.
Given the obvious inferiority of Rasuvo to Otrexup, and that Medac will face not only all the same insurance and sales difficulties that Antares already has, but the additional headwind of a competitor 9 months ahead of it - it seems surprising that Medac are not competing more notably on price.
I think you're spot on, noquick. Where is m_h_o when you need to hear what his contacts are whispering? :) As soon as I saw this news, I flipped over to look at our PPS, but the market so far hasn't caught on, it would seem.
We have to try and figure out the answer to your question. My guess is that the accretion to MNK, relative to QCOR, due to lower effective taxes on Acthar profits, is a DONE DEAL. However, the new rules surely cut the incentive for any US company to try and lower their own total taxation by buying out Mall (ie. being "bought out" by Mall.)
killdonkeys: I also wondered whether Antares salesmen tell the docs to whom they make pitches that Antares will be responsible for championing all patients that have these kinds of insurance difficulties - or just leave them to it. I was a long-term investor in a very successful company (Questcor) who took precisley that (former) stance.
It would be an interesting question for Jack, except I have no stomach to call the man any more. Bear in mind that the patient is atypical, because they cannot stomach oral MTX. All insurance companies are going to want very specific evidence of such before springing even for Otrexup.
Seems you just like to pull our chains. Same as camry but, on the side, you do good research.
We don't need beating down. This stock is a totally miserable, humiliating experience for any long.
Normally, I would have sold out ages ago, and moved way on. But I've even added in these depths, because I really think they will achieve things in the end, and I do not want to miss out, even though it's tying up enough capital as to kill my portfolio.
3 years in this now, waiting for someone in management that can actually manage to say something worthwhile on behalf of this company. They all seem totally passive. Contrast Wotton/Hobbs/Apple with - oh, say, Jobs, Bezos, Benioff. I'd even take Cook. At least he gets up and sings once a quarter.
Hi nammuang: I am guessing English is a 2nd language for you. whogo is quoting from a post on an RA forum. AFAIK, s/he is not the person answering Chartreux (another long-time poster and sufferer on the forum). Another poster, here, cacheflash, or some such, also has not grasped the vocative case of "Chartreux", and thinks it is Chartreux himself talking, so even English-as-1st-language people can have basic comprehension problems.
whogo is apparently offering a hypothesis as to the continuing low rate of growth of O Rx. He has previously indicated he works as a nurse, so I doubt he's a long-term RA sufferer. I do not know whether whogo is capable of, or has a taste for, pointing all this out to you.
loko: please just post what you know - or suspect. Sigh. Lose the drama.............and the periods. The comedy can stay.
Your posts remind me of someone that ate a huge mess of pig swill, thinking it was a vitamin supplement. But it is known that, somehow, a few possibly high-carat diamonds were accidentally dropped into the swill.
You periodically vomit up your meal, and we investors sort through the swill-vomit with our bare hands...................looking for diamonds.